Potentiation of chemotherapeutic agents following antagonism of nuclear factor kappa B in human gliomas (Q40596266)

21 September 2017

Potentiation of chemotherapeutic agents following antagonism of nuclear factor kappa B in human gliomas (English)

1 reference

21 September 2017

1 reference

Kyle D Weaver

1

1 reference

21 September 2017

Susan Yeyeodu

2

1 reference

21 September 2017

James C Cusack

3

1 reference

21 September 2017

Albert S Baldwin

4

1 reference

21 September 2017

Matthew G Ewend

5

1 reference

21 September 2017

1 February 2003

1 reference

Journal of Neuro-Oncology

21 September 2017

1 reference

21 September 2017

61

1 reference

21 September 2017

3

1 reference

21 September 2017

187-196

1 reference

https://scigraph.springernature.com/pub.10.1023/a:1022554824129

21 September 2017

0 references

cites work

Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway

1 reference

12 December 2020

Adenovirus-mediated gene transfer to the brain: methodological assessment

1 reference

12 December 2020

Tumor necrosis factor alpha induces the adenovirus early 3 promoter by activation of NF-kappaB.

1 reference

12 December 2020

Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2.

1 reference

12 December 2020

Multiple signals converging on NF-kappaB.

1 reference

12 December 2020

Suppression of TNF-alpha-induced apoptosis by NF-kappaB

1 reference

12 December 2020

c-Jun does not mediate hepatocyte apoptosis following NFkappaB inhibition and partial hepatectomy

1 reference

12 December 2020

Transcriptional cross talk between NF-kappaB and p53.

1 reference

12 December 2020

Inhibition of I kappaB-alpha phosphorylation at serine and tyrosine acts independently on sensitization to DNA damaging agents in human glioma cells

1 reference

12 December 2020

NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses

1 reference

12 December 2020

Adenovirus-mediated p53 gene therapy for human gliomas

1 reference

12 December 2020

Characterization of a neuronal kappaB-binding factor distinct from NF-kappaB

1 reference

12 December 2020

Adenovirus-mediated gene transduction of IkappaB or IkappaB plus Bax gene drastically enhances tumor necrosis factor (TNF)-induced apoptosis in human gliomas

1 reference

12 December 2020

The I kappa B proteins: multifunctional regulators of Rel/NF-kappa B transcription factors

1 reference

12 December 2020

A hydrophobic region within the adenovirus E1B 19 kDa protein is necessary for the transient inhibition of NF-kappaB activated by different stimuli.

1 reference

12 December 2020

The NF-kappa B and I kappa B proteins: new discoveries and insights

1 reference

12 December 2020

Adenovirally mediated gene transfer into experimental solid brain tumors and leptomeningeal cancer cells.

1 reference

12 December 2020

A requirement for NF-kappaB activation in Bcr-Abl-mediated transformation

1 reference

12 December 2020

Activation of multiple NF-kappa B/Rel DNA-binding complexes by tumor necrosis factor

1 reference

12 December 2020

Inducible chemoresistance to 7-ethyl-10-[4-(1-piperidino)-1-piperidino]-carbonyloxycamptothe cin (CPT-11) in colorectal cancer cells and a xenograft model is overcome by inhibition of nuclear factor-kappaB activation

1 reference

12 December 2020

Inhibition of nuclear factor-kappaB activation confers sensitivity to tumor necrosis factor-alpha by impairment of cell cycle progression in human glioma cells

1 reference

12 December 2020

Tumor necrosis factor induces Bcl-2 and Bcl-x expression through NFkappaB activation in primary hippocampal neurons

1 reference

12 December 2020

NF-kappa B: a crucial transcription factor for glial and neuronal cell function

1 reference

12 December 2020

A critical role for the RelA subunit of nuclear factor kappaB in regulation of multiple immune-response genes and in Fas-induced cell death

1 reference

12 December 2020

TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB

1 reference

12 December 2020

Requirement for NF-kappaB in osteoclast and B-cell development

1 reference

12 December 2020

Inhibition of NF-kappaB activity results in disruption of the apical ectodermal ridge and aberrant limb morphogenesis.

1 reference

12 December 2020

The dual effect of adenovirus type 5 E1A 13S protein on NF-kappaB activation is antagonized by E1B 19K.

1 reference

12 December 2020

Mapping of the inducible IkappaB phosphorylation sites that signal its ubiquitination and degradation

1 reference

12 December 2020

Enhancement of radiosensitivity by proteasome inhibition: implications for a role of NF-kappaB.

1 reference

12 December 2020

Inhibition of NF-kappaB activation in combination with bcl-2 expression allows for persistence of first-generation adenovirus vectors in the mouse liver

1 reference

12 December 2020

Inhibition of NF-kappa-B cellular function via specific targeting of the I-kappa-B-ubiquitin ligase

1 reference

12 December 2020

Requirement of NF-kappaB activation to suppress p53-independent apoptosis induced by oncogenic Ras.

1 reference

12 December 2020

Inhibition of NF-kappaB, clonogenicity, and radiosensitivity of human cancer cells

1 reference

12 December 2020

Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-kappaB

1 reference

12 December 2020

Inhibition of nuclear factor-kappaB activity is involved in E1A-mediated sensitization of radiation-induced apoptosis

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1022554824129

1 reference

Dimensions Publication ID

21 September 2017

0 references

1 reference